Kenny Walter

Anti-TNFs, vedolizumab, ustekinumab, thiopurines, and 5-ASA were all linked to a lower risk of myocardial infarctions.

Sulindac and eflornithine could help delay the need for lower gastrointestinal surgery for FAP patients.

Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.

Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.

More than half of the patient population achieved a defined response at both day 14 and week 6.

Research shows dupilumab remains effective in EoE for up to 2 years.

In data presented at ACG, investigators found a link between sex, lower BMI, and the development of irritable bowel syndrome in patients following a c. diff infection.

In a poster presented during ACG, investigators show data from a long-term extension of the UNIFI trial.

In data presented during Kidney Week, researchers find the risk of developed an acute kidney injury increased in both sickle cell trail and sickle cell disease patients.

Widespread increases in resting-state functional connectivity from the anterior medical prefrontal cortex and posterior cingulate cortex and frontal regions were found more in younger patients.

Precision medicine could have a major impact in ADHD.

Dr. Schaffner explains how social distancing and masks could also reduce the spread of influenza.

ADHD is associated with increased procedures, including blood transfusions, hospital admissions, and emergency department visits.

Dr. Albert discusses how preventative care and access to health care are important in closing health discrepancies.

Dr. Albert discusses some ways to close the racial outcome gaps in cardiology.

Stem cell transplantation can be a curative treatment for sickle cell disease, but there is some safety risks.

Relapses occurred in only 4 of 14 patients treated with the combination of Metronidazole with Vancomycin.

FDA application is based on the positive data from 3 recent phase 3 clinical trials.

Screenings for ADHD have not improved in several years.

A younger baseline age and more injections during the first year of treatment was linked to better long-term outcomes.

In data presented at UEG, investigators find post-dupilumab transcriptome closely resembles the transcriptome of a healthy control group.

Medications in psychiatry are often ineffective for patients.

Only 29.5% of sampled CBD users claimed any wellness benefit.

Dr. Cortese discusses how new research can drive changes to ADHD clinical trials.

The absolute SCr criterion correlated better with all-cause mortality than the relative increase in serum creatinine.

The younger generation is able to adapt to new technology for therapy better than previous generations.

Length of stay, cost, and the mortality rate all increase among patients with chronic kidney disease compared to patients who do not suffer from CKD.

The rate of maternal clinical insomnia has increased from 11% prior to the pandemic to 23% during the COVID-19 pandemic.

FDA predicts opioid stacking may occur because of the acute pain treatment.

Dr. Kliger discusses how nephrologists can safely treat patients this winter.